Novavax (NVAX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec12

FDA Plans to Issue 'Black Box' Warnings for COVID-19 Vaccines

10:30

Nov11

B. Riley Reaffirms Novavax 'Buy' Rating and Cuts Target Price

16:12

Nov6

Novavax released FY2025 9 Months earnings on November 6 Pre-Market (EST), actual revenue USD 976.34 M, actual EPS USD 2.3005

14:30

Novavax released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 70.45M (forecast USD 44.87M), actual EPS USD -1.25 (forecast USD -0.9167)

14:30

NovaVax Executives Forecast Significant Increase in Royalty Fees for 2026-2027 Flu Season

14:07

Novavax Reports Q3 EPS Loss of $1.25

13:52

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 70.45 M, Net Income -202.38 M, EPS -1.25

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 239.24 M, Net Income 106.51 M, EPS 0.6158

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 666.66 M, Net Income 518.65 M, EPS 2.9347

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change